Charles Schwab Investment Management Inc Revolution Medicines, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,931,114 shares of RVMD stock, worth $78.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,931,114
Previous 1,763,117
9.53%
Holding current value
$78.5 Million
Previous $79.9 Million
5.73%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding RVMD
# of Institutions
298Shares Held
179MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$695 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$545 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$539 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$440 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$386 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.57B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...